Filing Details
- Accession Number:
- 0001209191-18-004591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-19 17:03:03
- Reporting Period:
- 2017-12-27
- Accepted Time:
- 2018-01-19 17:03:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645460 | Cue Biopharma Inc. | CUE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571862 | Kenneth Pienta | 675 W. Kendall Street Cambridge MA 02142 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-27 | 2,000 | $7.50 | 2,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects shares of the Issuer's common stock that were purchased in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
